晶澳科技(002459.SZ):截止2024年年底組件產能將超100GW
格隆匯2月14日丨晶澳科技(002459.SZ)於近期投資者關係活動表示,截止2024年年底,公司組件產能將超100GW,硅片與電池產能達組件產能的80%,其中n型電池實際產能達70GW,基本滿足公司出貨需求。目前公司規劃建設的項目有鄂爾多斯一體化及阿曼電池組件項目。阿曼項目計劃於2025年開始推動建設,該項目建設符合公司全球化發展戰略需要。公司未來仍會綜合評估全球市場需求與公司實際產能情況,以高效的產品生產能力、良好的現金平衡能力,在行業週期底部保證可持續性經營,維持穩健發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.